732 related articles for article (PubMed ID: 19538366)
21. Understanding the pathogenesis of recessive dystrophic epidermolysis bullosa squamous cell carcinoma.
South AP; O'Toole EA
Dermatol Clin; 2010 Jan; 28(1):171-8. PubMed ID: 19945632
[TBL] [Abstract][Full Text] [Related]
22. Effective esophageal balloon dilation for esophageal stenosis in recessive dystrophic epidermolysis bullosa.
Okada T; Sasaki F; Shimizu H; Kato M; Nakagawa S; Sugihara T; Kawashima K; Todo S
Eur J Pediatr Surg; 2006 Apr; 16(2):115-9. PubMed ID: 16685618
[TBL] [Abstract][Full Text] [Related]
23. Transformation-specific matrix metalloproteinases (MMP)-7 and MMP-13 are expressed by tumour cells in epidermolysis bullosa-associated squamous cell carcinomas.
Kivisaari AK; Kallajoki M; Mirtti T; McGrath JA; Bauer JW; Weber F; Königová R; Sawamura D; Sato-Matsumura KC; Shimizu H; Csikós M; Sinemus K; Beckert W; Kähäri VM
Br J Dermatol; 2008 Apr; 158(4):778-85. PubMed ID: 18284387
[TBL] [Abstract][Full Text] [Related]
24. Recessive dystrophic epidermolysis bullosa skin displays a chronic growth-activated immunophenotype. Implications for carcinogenesis.
Smoller BA; McNutt NS; Carter DM; Gottlieb AB; Hsu A; Krueger J
Arch Dermatol; 1990 Jan; 126(1):78-83. PubMed ID: 1688702
[TBL] [Abstract][Full Text] [Related]
25. HLA and epidermolysis bullosa. Association between the HLA complex and recessive dystrophic epidermolysis bullosa.
Vaidya S; Tyring SK; Johnson LB; Fine JD
Arch Dermatol; 1991 Oct; 127(10):1524-7. PubMed ID: 1929459
[TBL] [Abstract][Full Text] [Related]
26. Reduced expression of insulin-like growth factor-binding protein-3 (IGFBP-3) in Squamous cell carcinoma complicating recessive dystrophic epidermolysis bullosa.
Mallipeddi R; Wessagowit V; South AP; Robson AM; Orchard GE; Eady RA; McGrath JA
J Invest Dermatol; 2004 May; 122(5):1302-9. PubMed ID: 15140235
[TBL] [Abstract][Full Text] [Related]
27. Three homozygous PTC mutations in the collagen type VII gene of patients affected by recessive dystrophic epidermolysis bullosa: analysis of transcript levels in dermal fibroblasts.
Gardella R; Zoppi N; Ferraboli S; Marini D; Tadini G; Barlati S; Colombi M
Hum Mutat; 1999; 13(6):439-52. PubMed ID: 10408773
[TBL] [Abstract][Full Text] [Related]
28. Amnia for intractable skin ulcers with recessive dystrophic epidermolysis bullosa: report of three cases.
Hasegawa T; Mizoguchi M; Haruna K; Mizuno Y; Muramatsu S; Suga Y; Ogawa H; Ikeda S
J Dermatol; 2007 May; 34(5):328-32. PubMed ID: 17408442
[TBL] [Abstract][Full Text] [Related]
29. Sentinel lymph node biopsy in recessive dystrophic epidermolysis bullosa and squamous cell carcinoma.
Perez-Naranjo L; Herrera-Saval A; Garcia-Bravo B; Perez-Bernal AM; Camacho F
Arch Dermatol; 2005 Jan; 141(1):110-1. PubMed ID: 15655164
[No Abstract] [Full Text] [Related]
30. Anchorless keratinocyte survival: an emerging pathogenic mechanism for squamous cell carcinoma in recessive dystrophic epidermolysis bullosa.
Rodeck U; Fertala A; Uitto J
Exp Dermatol; 2007 Jun; 16(6):465-7. PubMed ID: 17518985
[TBL] [Abstract][Full Text] [Related]
31. [Kidney diseases in dystrophic epidermolysis bullosa: case report].
Ducret F; Pointet P; Turc-Baron C; Vernin G
Nephrol Ther; 2008 Jun; 4(3):187-95. PubMed ID: 18243835
[TBL] [Abstract][Full Text] [Related]
32. Dystrophic epidermolysis bullosa complicated by cutaneous squamous cell carcinoma and pulmonary and renal amyloidosis.
Csikós M; Orosz Z; Bottlik G; Szöcs H; Szalai Z; Rozgonyi Z; Hársing J; Török E; Bruckner-Tuderman L; Horváth A; Kárpáti S
Clin Exp Dermatol; 2003 Mar; 28(2):163-6. PubMed ID: 12653705
[TBL] [Abstract][Full Text] [Related]
33. [Squamous cell carcinoma and recessive dystrophic epidermolysis bullosa].
Fourel E; Claudy AL
Ann Dermatol Venereol; 1992; 119(8):563-5. PubMed ID: 1485760
[TBL] [Abstract][Full Text] [Related]
34. Treatment of skin cancers in epidermolysis bullosa.
Venugopal SS; Murrell DF
Dermatol Clin; 2010 Apr; 28(2):283-7, ix-x. PubMed ID: 20447493
[TBL] [Abstract][Full Text] [Related]
35. Oral involvement of recessive dystrophic epidermolysis bullosa inversa.
Wright JT; Fine JD; Johnson LB; Steinmetz TT
Am J Med Genet; 1993 Dec; 47(8):1184-8. PubMed ID: 8291553
[TBL] [Abstract][Full Text] [Related]
36. Wound closure by secondary intention is successful in the treatment of squamous cell carcinomas in recessive dystrophic epidermolysis bullosa.
Rodríguez-Lojo R; Fernández-Jorge B; DE Andrés A; Peña C; García-Silva J
Eur J Dermatol; 2011; 21(2):302-3. PubMed ID: 21540143
[No Abstract] [Full Text] [Related]
37. Reconstruction in RDEB patients.
Huang L; Burd A
Ann Plast Surg; 2009 Dec; 63(6):693; author reply 693. PubMed ID: 19934850
[No Abstract] [Full Text] [Related]
38. [Phenytoin therapy in recessive dystrophic epidermolyses (epidermolysis bullosa dystrophica type Hallopeau-Siemens and epidermolysis bullosa dystrophica inversa)].
Wirth H; Nesch A; Ostapowicz B; Anton-Lamprecht I
Z Hautkr; 1983 Apr; 58(8):555-74. PubMed ID: 6858283
[TBL] [Abstract][Full Text] [Related]
39. Altered expression of L-arginine metabolism pathway genes in chronic wounds in recessive dystrophic epidermolysis bullosa.
Wessagowit V; Mallipeddi R; McGrath JA; South AP
Clin Exp Dermatol; 2004 Nov; 29(6):664-8. PubMed ID: 15550148
[TBL] [Abstract][Full Text] [Related]
40. A recurrent nonsense mutation occurring as a de novo event in a patient with recessive dystrophic epidermolysis bullosa.
Cuadrado-Corrales N; Sánchez-Jimeno C; García M; Ayuso C; De Lucas R; Vicario JL; Conti CJ; Zambruno G; Escamez MJ; Del Rio M
Dermatology; 2011; 223(3):219-21. PubMed ID: 21849769
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
